Mads Krogsgaard Thomsen, Novo Nordisk Foundation CEO
March 15, 2022 10:08 AM EDTUpdated March 18, 01:52 PM
R&D
Discovery

No­vo Nordisk, Gates Foun­da­tion pledge $90M to fund an­tivi­ral re­search for the next pan­dem­ic

Amber Tong

When the next pan­dem­ic hits, the No­vo Nordisk Foun­da­tion, Open Phil­an­thropy and the Bill & Melin­da Gates Foun­da­tion don’t want the world to be scram­bling …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Eu­ro­pean drug reg­u­la­tor re­vers­es opin­ion on Ei­sai and Bio­gen's Alzheimer's drug

Gilead will close Philadel­phia, Seat­tle of­fices as part of job re­duc­tions

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times